JPRN-UMIN000016598已完成未知
Study of visual and anatomical outcomes of second year aflibercept in good visual acuity baseline of wet age-related macular degeneration - Study of second year aflibercept in patients with wAMD
Department of Ophthalmology, Jichi Medical University0 个研究点目标入组 39 人开始时间: 2015年2月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 39
研究概览
简要总结
Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study. Shinichi Sakamoto, Hidenori Takahashi, Yuji Inoue, Yusuke Arai, Satoru Inoda, Natsuko Kakinuma, Yujiro Fujino, Tatsuro Tanabe, Hidetoshi Kawashima, Yasuo Yanagi Clinical ophthalmology (Auckland, N.Z.) 12 1137-1147 2018
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Greatest Linear Dimension (GLD) of the total lesion area <12 Macular Photocoagulation Study Disc Areas 2) Presence of subretinal hemorrhage, scar or macular fibrosis (>50% lesion area) 3) Prior treatment with anti-VEGF drug, photodynamic therapy 4) Prior treatment with dexamethasone (<6 months) or triamcinolone (<30 days), intraocular surgery (<3 months) 5) Active intraocular inflammation 6) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 7) Patient who the doctor in charge judges are ineligible for the study
研究者
相似试验
已完成
不适用
Study of visual and anatomical outcomes of aflibercept in good visual acuity baseline of wet age-related macular degeneratioAge-related macular degenerationJPRN-UMIN000011337Jichi Medical University39
已完成
4 期
Intravitreal Aflibercept for Submacular HemorrhageExudative Age-related Macular DegenerationNCT03169660Kim's Eye Hospital29
招募中
不适用
Aflibercept in Recurrent or Persistent CNVAge Related Macular DegenerationIntravitreal InjectionsDiabetic Macular EdemaNCT02669953Medical University of Vienna80
已完成
4 期
Effect Aflibercept on Ocular PerfusionAnti Vascular Endothelial Growth FactorMacular DegenerationNCT03804099Augenabteilung Allgemeines Krankenhaus Linz20
已完成
4 期
Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3Macular EdemaNCT03355638Università degli Studi di Brescia60